Abbott launches LCx chlamydia gene amplification test overseas.
This article was originally published in The Gray Sheet
Executive Summary
ABBOTT LAUNCHES LCx CHLAMYDIA TEST IN EUROPE, ASIA on May 26, the company said. The LCx system automates the detection phase, but not the amplification phase, of Abbott's ligase chain reaction DNA amplification technology. The chlamydia assay is the first gene amplification test to be launched by Abbott.